LDS/Medical Tests/Antinuclear Antibody (ANA), Body Fluid

Antinuclear Antibody (ANA), Body Fluid

Antinuclear antibodies (ANA) are a group of antibodies directed against various nuclear and some cytoplasmic cell antigens including dsDNA, ssDNA, RNP, Sm, SSA, and SSB. Antinuclear Antibodies are frequently observed in patients with autoimmune diseases, most commonly systemic lupus erythematosus (SLE). Positive ANAs may also be seen in other autoimmune diseases, including rheumatoid arthritis, collagen vascular diseases, chronic liver diseases, systemic sclerosis (scleroderma), Sjögren’s syndrome, and polymyositis/dermatomyositis. Immunoassay screening tests for ANAs are widely used and may be followed by a series of more specific markers that will help in the differential diagnosis of autoimmune diseases and/or disorders.

Immunoassay screening using enriched HEP-2 cell extracts has led to improved sensitivity compared to historical immunofluorescence methods. Because of the multi-antigenic nature of the test, false positive test results may occur in apparently healthy individuals; therefore, patients should be evaluated in consideration of complete physical presentation. Additional laboratory testing can be considered to confirm and evaluate positive screen results. Options available are Immunofluorescence Assay (IFA) testing or antigen specific cascades to evaluate specificity.

Aids in diagnosis of various autoimmune diseases such as:

  • Systemic Lupus Erythematosus
  • Mixed Connective Tissue Disease
  • Dermatomyositis
  • Polymyositis
  • Rheumatoid Arthritis
  • CREST Syndrome
  • Sjögren’s syndrome
  • Collagen vascular diseases

Elevated in:

  • Autoimmune diseases such as systemic lupus erythematosus (SLE) Discoid lupus and drug-induced lupus
  • Sjögren’s syndrome
  • Rheumatoid arthritis
  • Scleroderma
  • Mixed connective tissue disease
  • Dermatomyositis
  • Polymyositis
  • Also increased in liver cirrhosis, hepatitis, leukemia, myasthenia gravis, chronic renal failure, infectious mononucleosis

Note: This is a screening test and its specificity is very low. Patients over age 65 or pregnant women might have a positive (usually low titers) ANA screen with no underlying autoimmune disease.

Negative (Non-reactive)

If semiquantitative: <0.9 index value

 

 

ELISA, enzyme immunoassay, multiplexing immunoassay

Serum (SST)

Stability

  • Ambient: 48 hours
  • Refrigerated: 7 days
  • Frozen: 60 days
If positive, the test should be confirmed with specific antigens (see ANA antigen specific profile) or by indirect immunoflourescence assay (pattern of ANA staining). Rheumatoid Factor, Comprehensive Metabolic Panel, CRP, Anticardiolipin Antibody, IgA, IgG, IgM, Anti-DNA, Anti-phospholipid antibody, Complement C3 and C4, Cyclic citrullinated peptide antibody IgG, SS-A/Ro autoAb, SS-B/La antoAb, Sm autoAb, anti-RNP, Scl-70 autoAb, Jo-1 autoAb, Centromere antibodies IgG serum, Ribosom P antibodies IgG.
Within 1 day after receipt in performing laboratory.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Rinsho Byori. 2005 Jun;53(6):562-9. [PMID: 16026086]
  • Scand J Rheumatol. 2005 Jul-Aug;34(4):260-8. [PMID: 16195158]
  • Clin Immunol Immunopathol. 1998 Sep;88(3):211-20. [PMID: 9743606]
  • J Rheumatol. 2005 Sep;32(9):1643-9. [PMID: 16142854]
  • Arch Pathol Lab Med. 1998 Nov;122(11):993-9. [PMID: 9822128]
  • Autoimmun Rev. 2008 Sep;7(8):588-93. [PMID: 18617021]
  • Am J Clin Pathol. 2002;117:316. [PMID: 11863229]
  • J Nephrol. 2002 Nov-Dec;15 Suppl 6:S20-7. [PMID: 12515370]
  • Scand J Immunol. 2006;64:227. [PMID: 16918691]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757